QuartzBio Team, Author at QuartzBio

About QuartzBio Team

This author has not written his bio yet.
But we are proud to say that QuartzBio Team contributed 34 entries already.

Entries by QuartzBio Team

From Optimism to Opportunity: Evolving Impacts of AI on Precision Medicine

The explosion of generative AI and domain-specific AI agents has created renewed energy, focus and promise around the hype of AI impacting the R&D lifecycle. Generative AI is revolutionizing precision medicine clinical trial planning, execution, and operations. Organizations are increasingly recognizing its potential, rallying behind AI initiatives. The race is on – the race to leverage AI as a force multiplier, knowledge amplifier and value generator, ultimately accelerating time-to-insight. In this post, we explore concrete ways in which generative AI can deliver on these promises.

AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024

Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference. Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development.

Key Takeaways: Biomarker Intelligence Summit, March 2024

Last week, biomarker intelligence leaders from Boston-area R&D organizations got a firsthand look at the powerful predictive and prescriptive intelligence that will soon infuse QuartzBio’s AI Biomarker Intelligence Platform, after sharing common challenges facing data-rich precision medicine clinical programs.

Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials

Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at SCOPE 2024 by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem.

Webinar On Demand: Taming clinical sample chaos with conversational AI

Learn how conversational AI enables you to talk to your biospecimen data. Join Bill Hall for a demo of our virtual Sample Inventory Management solution, powered by an AI-enabled Biomarker Intelligence Platform and intuitive Virtual Assistant.

Meet a QuartzBio Employee: Katie Berola

QuartzBio’s team has deep experience in technology-enabled solutions for the life science industry. In this blog series, we invited you to get to know a member of the QuartzBio team. This month, we are delighted to talk with Katie Berola, Director of virtual Sample Inventory Management.

Spotlight on Specimens: Innovations in Biospecimen Management May Transform Precision Medicine

In a recent article titled, “The Criticality of Specimen Management to Precision Medicine,” Brenda Yanak warned drug developers against minimizing the importance of biospecimens, so often overlooked during biomarker development.

Webinar On Demand: Unifying Clinical & Biomarker Data

Join Bill Hall for a webinar demo of the QuartzBio® enterprise Biomarker Data Management solution. We’ll show you how to generate patient profiles to view tumor burden over course of treatment, explore multi-marker views of patient profiles, and cross-reference biomarker measures across file types.

Webinar On Demand: Digitizing Biomarker Operations–Tools to Track & Report Sample, Consent, Vendor, & Site KPIs Across Programs

Join our webinar to learn how our clients, representing major biopharmas and biotechnology companies, have eliminated tedious data management processes and costly delays with the QuartzBio® virtual Sample Inventory Management SaaS solution.

QuartzBio Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development

Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.